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Process Robustness and Cell Line Variation in N-1 High Density Perfusion 
System 
 
Haofan Peng, Brandi Arterberry, Patrick Johnstone, Alex Doane, William Yang, Weiwei 
Hu, Kelly Wiltberger, and Erik Hughes 
 
In newly developed Biogen manufacturing processes, we are using perfusion technology 
to shift the cell growth phase into the seed train from the production reactor. This change 
improves facility throughput 30% by reducing time within the production bioreactor. In 
order to implement this approach, a hollow fiber based tangential flow filtration (TFF) 
system has been utilized in both lab and manufacturing settings.  In defining the 
laboratory scale model, a case study showed that inadequate pumps and tubing can 
result in significant cell damage which was only observed at high cell densities. After 
integrating the non-spallation tubing with peristaltic pump, a TFF perfusion bioreactor can 
work as well as ATF system (Alternate Tangential flow filtration).  To ensure successful 
scale-up, we also assessed the impact of volumetric throughput, hydrodynamic shear, 
and perfusion medium feeding strategy within laboratory experiments.   Process 
robustness were also evaluated including cell damage from high sparging, the impact of 
low mass transfer capability and the extended residence time during recirculation.   Given 
the associated capital costs and long term production needs, assessing the robustness 
of the approach for inclusion in current and future programs becomes critical.  Work on 
several CHO cell lines has begun in order to compare the cellular response to the addition 
of this step.   Within this work, we will present a perfusion TFF model for scale up of cells 
in the N-1 bioreactor and report on methods assessing its suitability as a platform 
approach.  
 
 
 
